Stock CORV CORREVIO PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Correvio Pharma Corp. Nasdaq

Equities

CORV

CA22026V1058

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Correvio Pharma Corp. +1.06% +2.41%
2020 Mark Corrigan Departs as CEO from Correvio Pharma Corp CI
2020 Justin Renz, CFO Departs from Correvio Pharma Corp CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Correvio Pharma Corp. Reiterates Revenue Guidance for the Full-Year 2019
Cardiome Pharma Corp. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Provides Revenue Guidance for the Year 2017
Cardiome Pharma Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017; Provides Revenue Guidance for the Year 2018
Cardiome Pharma Corp. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Provides Revenue Guidance for the Full Year of 2017
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CORV Stock
  4. CORV Stock
  5. News Correvio Pharma Corp.
  6. Other languages